GlassScriptPhysician profile
Savitha Bhat Kasturi
NPI 1912162934
$4,418.03
in general payments reported to CMS, 2019-2025
29 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,492 · 2020: $777 · 2021: $549 · 2022: $483 · 2023: $524 · 2024: $228 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $843.50 | 2019-2024 | Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $637.73 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $529.42 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.84 | 2019-2023 | Jardiance |
| Amgen INC. | $339.03 | 2019-2025 | Otezla, Repatha |
| Lilly USA, LLC | $317.25 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $172.46 | 2019-2024 | |
| Abbvie INC. | $168.02 | 2021-2023 | |
| Exact Sciences Corporation | $155.08 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $131.36 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $130.34 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $107.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.65 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $89.41 | 2019-2022 | |
| Abbott Laboratories | $41.22 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.65 | 2020-2021 | |
| Esperion Therapeutics, INC. | $36.27 | 2020-2021 | |
| Medtronic, INC. | $27.66 | 2024 | Minimed 780g |
| Merck Sharp & Dohme LLC | $26.77 | 2019-2020 | |
| Renalytix Ai, INC. | $24.56 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Ethicon US, LLC | $22.86 | 2019 | |
| Azurity Pharmaceuticals, INC. | $18.74 | 2025 | Alvesco |
| Teva Pharmaceuticals USA, INC. | $18.00 | 2020 | |
| Arbor Pharmaceuticals, INC. | $15.00 | 2020 | |
| Radius Health, INC. | $13.94 | 2019 | |
| Astellas Pharma US INC | $13.21 | 2023 | Myrbetriq |
| Lucid Diagnostics INC. | $13.04 | 2023 | |
| Amarin Pharma, INC. | $12.88 | 2019 | |
| Allergan, INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savitha Kasturi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.